Talks
CKD & Gout at ASN Kidney Week
October 16, 2024
Vera Therapeutics @ ASN Kidney Week
October 10, 2024
ASN 2024 is Coming Soon!
October 8, 2024
The Effects of Laughter on DED Symptoms
September 24, 2024
Peripheral Neuropathy and DED
September 24, 2024
AI in Ophthalmology
September 24, 2024
Bayer
November 3, 2022
Aurinia Pharma
November 3, 2022
Regulus
November 3, 2022
Dry Eye Management
October 3, 2022
VR Education
October 3, 2022
AI in practice
October 2, 2022
Managing TED
October 2, 2022
Live podcast!
October 2, 2022
Ask the Experts
October 2, 2022
Advances in Tech
October 2, 2022
AAO Day 2!
October 2, 2022
Age in Management
October 1, 2022
Symposium @ AAO
October 1, 2022
ililli @ AAO
October 1, 2022
Clearside Biomedical
September 28, 2022
Ocular Therapeutix
September 28, 2022
Outlook Therapeutics
September 28, 2022
ililli @ AAO
September 28, 2022
Predicine @ ESMO
September 9, 2022
GRAIL
September 9, 2022
Curelab Oncology
September 9, 2022
ESMO starts today!
September 9, 2022
Guardant Health
September 6, 2022
Median Technologies
September 6, 2022
PDW @ ENDO
June 10, 2022
Dr. Pereira @ ENDO
June 10, 2022
Thyroid Nodules
June 10, 2022
Dr. Hebrok @ ENDO
June 10, 2022
ENDO starts soon
June 10, 2022
ENDO is tomorrow!
June 10, 2022
Amryt @ ENDO
June 9, 2022
Cedars-Sinai
June 9, 2022
Soleno Therapeutics
June 9, 2022
BridgeBio Pharma
June 9, 2022
Aurinia
April 7, 2022
Akebia Therapeutics
April 7, 2022
Outset Medical
April 7, 2022
Panavance @ ASCO
January 19, 2022
Natera @ ASCO
January 19, 2022
Guardant Health
January 19, 2022
ASCO GI is tomorrow!
January 19, 2022
Eisai @ ASCO GI
January 18, 2022
Kinnate Biopharma
January 13, 2022
Transcenta @ ASCO GI
January 13, 2022
AZ @ ASCO GI
January 13, 2022
ASCO GI 1 Week Away!
January 13, 2022
Panbela Therapeutics
January 12, 2022
TYME Technologies
January 12, 2022
New Model of Onc
December 7, 2021
Neovascular AMD
November 12, 2021
Clinical Trials
November 12, 2021
Late Breaking
November 12, 2021
Retina @ AAO
November 12, 2021
Emerging Treatments
November 12, 2021
Close button
Why are you reporting this TALK?